Table 1 Demographic and clinical characteristics of the patients enrolled in the study.

From: Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients

 

MILD

 

SEVERE

  

n

%

n

%

p

Number

29

 

50

  

Male sex

17

58.6

35

70.0

0.694*

Mortality

0

0.0

41

82.0

0.000*

Hypertension

17

58.6

30

60.0

1.000*

Diabetes

11

37.9

25

50.0

0.782*

Obesity

3

10.3

12

24.0

0.527*

Chronic kidney disease

3

10.3

4

8.0

0.989*

Chronic heart disease

6

20.7

10

20.0

1.000*

Chronic pulmonary disease

2

6.9

7

14.0

0.821*

Immunosuppressive drugs

12

41.4

33

66.0

0.209*

 

Median

IQR

Median

IQR

p

Age

61

(51–73)

63.5

(55.2–69)

0.8786**

Days of symptoms

7

(4–10)

8

(5–11)

0.269**

Leukocytes

7.17

(5.77–9.57)

10.6

(7.52–12.8)

0.014**

Neutrophils

6.11

(4.3–8.14)

9.15

(6.4–11.4)

0.004**

Lymphocytes

0.99

(0.68–1.59)

0.915

(0.57–1.26)

0.261**

CRP

102

(47.6–161)

156

(85.9–224)

0.0197**

  1. Variables are expressed as number (%) or median (interquartile range). Bolded values indicated variables with statistically significant associations (significance level of 0.05).
  2. *P values were calculated using the chi-square test in R software (version 4.0.3 for macOS).
  3. **P values were calculated using the nonparametric Mann–Whitney test in R software (version 4.0.3 for macOS), that tests for trend across ordered groups.
Back to article page